Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: the TT4 randomized trial.
Francioso S, Almerighi C, Forte P, Bandiera F, Nosotti L, Lionetti R, Taliani G, Piras MR, Ponti ML, Parruti G, Di Candilo F, Gentile S, Piccolo P, Salso A, Riccobelli F, Renzi S, Longo MA, Montalbano M, Zaru S, Biliotti E, Di Masi F, Santopaolo F, Angelico M. Francioso S, et al. Among authors: bandiera f. Dig Liver Dis. 2014 Feb;46(2):164-9. doi: 10.1016/j.dld.2013.10.002. Epub 2013 Nov 13. Dig Liver Dis. 2014. PMID: 24239044 Clinical Trial.
Peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a monotherapy in early virological responders and peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a, ribavirin and amantadine triple therapy in early virological nonresponders: the SMIEC II trial in naïve patients with chronic hepatitis C.
Angelico M, Koehler-Horst B, Piccolo P, Angelico F, Gentile S, Francioso S, Tarquini P, Vecchia RD, Ponti L, Pilleri G, Barlattani A, Grieco A, Soccorsi F, Guarascio P, Demelia L, Sorbello O, Rossi Z, Forlini G, Zaru S, Bandiera F; SMIEC II Investigators. Angelico M, et al. Among authors: bandiera f. Eur J Gastroenterol Hepatol. 2008 Jul;20(7):680-7. doi: 10.1097/MEG.0b013e3282f5196c. Eur J Gastroenterol Hepatol. 2008. PMID: 18679072 Clinical Trial.
Patterns of chronic hepatitis B in Central Italy: a cross-sectional study.
Piccolo P, Lenci I, Telesca C, Di Paolo D, Bandiera F, De Melia L, Sorbello O, Renier G, Ricci GL, Nosotti L, Romano M, De Santis A, Levrero M, Antonucci G, Longo MA, Annicchiarico BE, Angelico M; Hep B Free Network Investigators. Piccolo P, et al. Among authors: bandiera f. Eur J Public Health. 2010 Dec;20(6):711-3. doi: 10.1093/eurpub/ckp168. Epub 2009 Nov 2. Eur J Public Health. 2010. PMID: 19884157
Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3.
Mangia A, Bandiera F, Montalto G, Mottola L, Piazzolla V, Minerva N, Pellicelli A, Ricci GL, Cela M, Carretta V, Scotto G, Bacca D, Annicchiarico B, Romano M, Russello M, Barbarini G, Agostinacchio E, Andriulli A. Mangia A, et al. Among authors: bandiera f. J Hepatol. 2010 Dec;53(6):1000-5. doi: 10.1016/j.jhep.2010.04.042. Epub 2010 Aug 4. J Hepatol. 2010. PMID: 20843575 Clinical Trial.
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study.
Vaira LA, De Vito A, Deiana G, Pes C, Giovanditto F, Fiore V, Lechien JR, Le Bon SD, Saussez S, Madeddu G, Babudieri S, Pazzola A, Bandiera F, Fois AG, Piana AF, Hopkins C, De Riu G. Vaira LA, et al. Among authors: bandiera f. Eur Arch Otorhinolaryngol. 2022 Feb;279(2):811-816. doi: 10.1007/s00405-021-06868-5. Epub 2021 May 13. Eur Arch Otorhinolaryngol. 2022. PMID: 33983525 Free PMC article.
73 results